As of May 27
| -1.19 / -1.23%|
The 29 analysts offering 12-month price forecasts for Bayer have a median target of 138.21, with a high estimate of 160.57 and a low estimate of 113.15. The median estimate represents a +45.15% increase from the last price of 95.22.
The current consensus among 32 polled investment analysts is to Buy stock in Bayer. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.